Evolent Health, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Evolent Health, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2015 to Q2 2024.
  • Evolent Health, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $12.7M, a 41.2% increase year-over-year.
  • Evolent Health, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $52.3M, a 26.6% increase year-over-year.
  • Evolent Health, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40.5M, a 19.2% increase from 2022.
  • Evolent Health, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $34M, a 103% increase from 2021.
  • Evolent Health, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16.7M, a 14.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $52.3M $12.7M +$3.69M +41.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $48.6M $18.8M +$8.08M +75.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $40.5M $10.6M -$4.03M -27.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $44.5M $10.2M +$3.23M +46.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $41.3M $8.97M +$1.95M +27.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $39.3M $10.7M +$5.36M +100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $34M $14.6M +$9.67M +195% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $24.3M $6.99M +$2.6M +59.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $21.7M $7.01M +$3.36M +92% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $18.4M $5.35M +$1.64M +44.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $16.7M $4.96M +$726K +17.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $16M $4.4M +$1.23M +38.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $14.8M $3.65M -$50K -1.35% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $14.8M $3.71M +$198K +5.64% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $14.6M $4.23M +$3.66M +638% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $10.9M $3.16M -$2.59M -45.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $13.5M $3.7M -$1.05M -22% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $14.6M $3.51M -$1.03M -22.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $15.6M $573K -$4.48M -88.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $20.1M $5.76M +$1.71M +42.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $18.4M $4.75M +$32K +0.68% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $18.4M $4.54M +$742K +19.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
Q4 2018 $17.6M $5.05M +$784K +18.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $16.8M $4.05M -$1.66M -29.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $18.5M $4.72M -$642K -12% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $19.1M $3.8M -$1.31M -25.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $20.4M $4.27M -$4.39M -50.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $24.8M $5.71M +$909K +18.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $23.9M $5.36M +$651K +13.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $23.3M $5.1M +$769K +17.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $22.5M $8.66M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $4.8M +$417K +9.52% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $4.71M -$1.45M -23.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $4.34M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 $4.38M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $6.15M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.